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Abstract 
 
 The goal of this review is to provide an overview of the process by which policy is 
developed for complex animal diseases. There is no one size fits all approach to policy. 
Policy making for a disease is complex, often a bit disorderly, and like medicine not an 
exact science. The current mission behind the United States Department of Agriculture, 
Animal and Plant Health Inspection Service, Veterinary Services (USDA, APHIS-VS) and its 
role in the One Health partnership is to adequately contribute to the animal health 
component. One Health is a crucial component behind the response to any emerging 
disease because of the interrelatedness of animal, human, and environmental health. The 
following document strives to further support the advancement of the One Health concept 
as it relates to complex animal diseases.  
 
 This review also illustrates just what can happen when a student becomes an 
integrated part of One Health and public policy. Throughout the development of this paper, 
I found myself diving right into the very concepts that I had previously only seen and heard 
in the classroom. This paper serves not only as an APHIS training document, but as 
substantial evidence of how a field experience can turn an array of concepts into a 
workable puzzle by which one builds a career dedicated to One Health.  
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Chapter 1: What is One Health? 
 
The One Health Experience 
 
 The One Health Coordination Center (OHCC) as part of the USDA, APHIS- Veterinary 
Services Surveillance, Preparedness, and Response Services (SPRS) unit in Riverdale, 
Maryland was the primary location for my six-week field experience. My main mentor and 
supervisor throughout this experience was, Dr. Joseph Annelli, the Director of the One 
Health Coordination Center. Maria Romano, a current third year veterinary student at 
Virginia-Maryland Regional College of Veterinary Medicine and Saul T. Wilson Jr. scholar as 
well as Ryan Freed, a third year veterinary student from the University of Illinois, were also 
major collaborators during my six week experience.  
 
One Health (OH) - what is it and what does it mean? 
 
“Between animal and human medicine there is no dividing line –nor should there be. The 
object is different but the experience constitutes the basis of all medicine.” –Rudolf 
Virchow, German scholar (1800s)  
 
  The idea that the health of animals, humans, and the environment are synergistically 
linked is the driving force behind the current practice of One Health (OH). Over time, the 
unifying goal of controlling and preventing disease and improving health at the level of the 
human, animal, environmental interface has brought public and private organizations from 
different disciplines together. In the last three decades, the need for an OH approach has 
increased in importance (25). This increase is due to changing global dynamics; for 
example, population growth, ecological changes, and globalization. In a globalized society, 
as the population continues to grow, the movement of animals and humans will inevitably 
increase. Increased movement presents an opportunity for an increased risk of disease 
transmission, especially new or emerging diseases, many of which are zoonotic diseases.  
 
One Health and Veterinary Services (VS) – the role VS plays in the One Health 
partnership 
 Since the mid-1900s, with the initiation of the Bovine Tuberculosis and Brucellosis 
programs, VS has played a crucial role in impacting public health with the control of several 
zoonotic diseases (25).  Since then, the need and involvement of VS has grown. The 
emergence of diseases like the 2006 highly pathogenic avian influenza (HPAI) H5N1 
epizootic, have not only affirmed a need for VS involvement, but has illustrated the 
importance of a collaborative effort among many different disciplines and organizations. As 
a result, the OH component of VS has continued to evolve to meet the demands of animal 
health and enhance the ability to address human and environmental problems.  
 
The current mission or focus of the OH group of VS is to build on new and existing 
collaborations while also enhancing communication and outreach. APHIS strives to 
increase the APHIS-VS stakeholders and adequately contribute to the animal health 
component of the OH partnership (24).  In partial fulfillment of this mission the OHCC was 
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created. The OHCC is an organizational structure established to facilitate incorporation of 
OH into every aspect of the VS community. Additionally, the creation of the OHCC also 
illustrates to the outside community and OH partners how VS is incorporating OH into its 
infrastructure (22).  
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Chapter 2: Introduction to Public Policy 
 
What are the criteria for animal health public policy development? 
The decision of what constitutes the need for regulations or policies is not clearly 
defined and involves a unique process that varies based on the situation.  Veterinary 
Service’s role in policy historically has been to manage issues concerning livestock and 
poultry health and issues related to trade. The current animal health mission goes further 
to indicate that the VS role in policy will embrace all aspects of animal health, including 
wildlife. APHIS, VS recognizes that human health is impacted by the health of animals and 
as defined by the current mission, stated by John Clifford, APHIS Deputy Administrator for 
VS, “APHIS Veterinary Services is committed to providing all of our stakeholders and 
partners with superior customer service and effective partnerships. VS’ reorganization is 
designed to better align our organization with our animal health mission allowing VS to 
continue to deliver our services efficiently and effectively (22).”  
 
Similar to medicine, the principles behind animal and OH policy are not an exact 
science. The inner complexity of public policy is intricate and dependent on a variety of 
factors leading to a need for balance. These factors can range from political to social to 
economic and everything in between. There is no one right answer to the formulation of 
public policy. Instead, the answer lies in finding a solution that minimizes the impacts on 
animal, human, and environmental health. The process can take months to years depending 
on the situation, and some policies never come to fruition because more benefit can come 
from enacting other measures.  
 
When does VS act? 
The question remains as to 
when the government should get 
involved and if a policy is necessary 
to achieve an outcome.  Again, this is 
not clear and a variety of 
contributing factors must be 
considered.  
 
The members of VS have 
proposed a clever way to decide 
whether engagement or response is 
required for a particular emerging 
infectious disease. They have 
established a decision matrix for this 
purpose. The matrix is a simple table 
with several criteria that are 
compared to four different columns along a continuum. This framework gives decision 
makers an additional tool to use when deciding appropriate involvement and response 
(23). The tool is also something that could be re-visited occasionally, especially as new 
information is learned about a particular disease (Appendix I, II).  
 
Figure 1: One Health engagement flowchart, created by APHIS, VS 
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Regardless of the framework used to establish when and if action should be taken, it 
is important to consider the various ‘triggers’ that might overrule any scientific-based 
decisions (23). A trigger is anything that has an overwhelming impact on the personal or 
public viewpoint of a particular issue. An example of a trigger to action can be described 
using the Accelerated Pseudorabies Eradication Program. The severe economic losses 
incurred by the United States (U.S.) swine industry acted as a trigger aiding in the decision 
to respond. In other cases, the decision is simply a political statement inciting a need for 
policy in a particular area. Situations, such as the consideration of which zoonotic diseases 
should be a priority, depends on triggers, science, and other influencing factors to decide 
just what should be a main focus (28). This focus, like many things, is subject to change 
with time as new diseases emerge, re-emerge, or as new information is acquired.  
 
 While it is often true that triggers and other influencing factors impact whether VS 
takes action on a particular area, there is one more area that requires consideration.  More 
often than not, it is Congress that makes the decision by passing a bill, delegating funds to 
be spent on a specific program or area of interest.  This is true for many of the U.S. program 
diseases, which includes the Accelerated Pseudorabies Eradication Program, discussed 
earlier. The delegation of financial support from Congress is often the most significant 
factor in the decision making process. Historically, financial support was primarily 
designated towards those diseases with an established program. The recent reorganization 
of the federal agencies has allowed for the allotment of funds to be directed towards 
program diseases and any disease of OH concern. This is an important change as it provides 
VS with the ability to reach farther towards the prevention and control of diseases of OH 
significance.   
 
Emerging Disease vs. Foreign Animal Disease – Is there a difference? 
To demonstrate the continuous work being done to provide a more coordinated and 
concise approach to the management of complex animal diseases, a recent VS guidance has 
been constructed to formally define both foreign and emerging animal diseases. As defined 
by the VS guidance, a foreign animal disease (FAD) is a terrestrial animal disease or pest, or 
an aquatic animal disease or pest, not known to exist in the United States or its territories 
(6).  
 
To further refine this definition, an FAD is considered to be one of forty diseases 
recognized by the Committee on Foreign and Emerging Diseases. This committee, as part of 
the U.S. Animal Health Association (USAHA), meets annually to discuss the current list of 
foreign animal diseases. A disease previously not identified as an FAD can be added to the 
list as the committee deems appropriate. Animal health officials formally define a disease 
worthy of consideration for the FAD list as, “an important transmissible livestock or 
poultry disease believed to be absent from the U.S. and its territories that has a significant 
health or economic impact.” Historically, this list includes all FAD’s considered to be of the 
greatest threat to the livestock and poultry industries in the U.S (30).  
 
In comparison, the VS guidance further defines an emerging infectious disease 
(EID), as any terrestrial animal, aquatic animal, or zoonotic disease not yet known or 
characterized, or any known or characterized terrestrial animal or aquatic animal disease 
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in the United States or its territories that changes or mutates in pathogenicity, 
communicability, or zoonotic potential to become a threat to terrestrial animals, aquatic 
animals, or humans (6).  
 
To summarize, an EID is any animal disease of novel or evolving nature that is either 
known or not known to exist in the United States. A “foreign” animal disease which has not 
previously been identified as an FAD and is currently a threat to animals or humans is 
considered an EID. For example, Porcine Epidemic Disease virus (PEDv) is currently 
considered an EID. Prior to its introduction to the U.S., PEDv was only known to exist 
outside the U.S., but it was never considered of importance to be included on the list of 
FAD’s. Overtime, this might change if either the USAHA or the World Organization for 
Animal Health (OIE) deems PEDv worthy of an upgrade from EID to FAD. An example of a 
case where this has occurred can be described using HPAI-H5N1. Initially, HPAI-H5N1 was 
considered to be an EID, but overtime as the threat became global the OIE deemed it 
appropriate to upgrade HPAI-H5N1 to FAD status.  
 
The dividing line between an FAD and EID is not really all that clear outside of 
personal opinions. The distinction between an EID and FAD is not based completely on 
science-based principles, and the same goes for the principles behind policy development. 
Sometimes all it takes is a group of people meeting around a round table to agree that a 
disease in question is an FAD or EID. Decision making and policy development are highly 
variable and depend on a variety of factors. All decisions are likely to change as new 
information is gathered about a disease. Therefore, a successful response requires that a 
sense of flexibility be present throughout every aspect of the process from creating 
definitions to the disease program implementation.  
 
Birds, Policy, and the OH approach 
A perfect example of how policy has been formulated around an emerging infectious 
disease can be described using the evolution of the National Avian Influenza Surveillance 
Plan. The initial HPAI-H5N1 epizootic promoted the development of a national surveillance 
program as countries worldwide scrambled to understand the virus. In September 2005, 
President George W. Bush created the International Partnership on Avian and Pandemic 
Influenza. This partnership was formed to make Avian Influenza (AI) the focal point on 
national agendas.  Following this induction, the United States hosted the first international 
conference in October 2005. Since then, several conferences have been held worldwide. 
The conference brought an emerging issue into plain sight. It helped coordinate and 
mobilize resources needed to improve containment, response, and prevention of future 
pandemic threats (26). Additionally, President Bush established the National Strategy for 
Pandemic Influenza and assigned the lead role to the Department of State. In support of 
both the National Strategy and Department of State Pandemic Influenza plans, the Under 
Secretary for Democracy and Global Affairs established the AI action group. This action 
group was designed to serve as a collaborative effort between several government agencies 
allowing for efficient maintenance and coordination of U.S. information on AI and the 
ongoing epizootic (8).  
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Since 2005, there have been several outbreaks in Asia, Europe, and Africa. HPAI-
H5N1 has transitioned from an emerging disease to being classified as a foreign animal 
disease by the OIE. Part of this is due to the economic and social impact of the disease, but 
much of it is also due to its evolving nature and ability to infect birds and mammals, 
including humans. The initial regulatory framework has set the stage. However, as we 
embark farther into the future, it is clear that there is a need for constant improvement 
(26).  
 
Due to its success, the AI regulatory framework has served as a basis for the 
regulatory framework of other emerging and re-emerging infectious diseases. These 
beginning steps have in many ways strengthened our ability to respond and brought 
together disciplines and organizations across continents. All these factors demonstrate 
how policy can impact the course of emerging disease within the United States and abroad. 
With recent emergence of diseases, such as avian influenza H7N9, it is clear that our fight 
has only just begun.  
 
 In 2007, a combined effort from the American Veterinary Medical Association 
(AVMA) and American Medical Association (AMA) set into motion the development of a 
One Health Initiative task force that further supports the vision of the OH concept (25). 
This task force created a bridge for veterinarians, physicians, and U.S. animal and human 
health agencies to communicate and collaborate effectively on matters related to the 
human, animal, and environmental interface. The OH initiative task force combined with 
the global effects of the National Strategy for Pandemic Influenza and its Implementation 
plan promoted further growth and adoption of the OH concept at home and abroad.   
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Chapter 3: Background information 
 
Background Research and Communication  
For many diseases, exploring what is known can become quite expansive. The 
amount of research depends on the novelty or nature of the disease or how much is already 
known about it. In the case of a novel virus that has recently emerged, very little 
information will be known. Typically, there is need for extensive study to determine the 
epidemiologic characteristics of the disease.  
 
A current example of this is the emergence of Middle Eastern Respiratory 
Syndrome, which is caused by a coronavirus (MERS-CoV). MERS-CoV is reported to be of 
camel origin and the cause of severe respiratory illness in humans. To date, only mild 
illness has been reported in camels with most showing no clinical signs. MERS-CoV is most 
closely related to Sudden Acute Respiratory Syndrome (SARS) another coronavirus of 
historical significance. The impact on the human population amongst the Middle Eastern 
countries, risk to travelers, and relation to a historical pandemic tags MERS-CoV as a 
significant disease for further investigation.  While there is evidence of zoonotic 
transmission through close contact with camels there is simply not enough information 
known about the modes of transmission to extrapolate the source of human exposure. This 
illustrates the limitations arising from incomplete data due to novelty of a disease.   
  
 The background research on a particular interest area or disease usually strives to 
cover the basic epidemiology of the disease, but it can involve investigation of other factors. 
Other factors may include but are not limited to: cultural aspects, regional differences, 
climate, etc. For example, a cultural difference between the U.S. and Asia that has an impact 
on the transmissibility of AI is related to the importance of live poultry markets in Asia, and 
the difference in care and management of the birds. Generally, birds live in much closer 
proximity to people throughout Asia and there is also less knowledge of biosecurity. It is 
also harder to completely depopulate flocks in communities throughout Asia due to 
economic circumstances and cultural beliefs. Therefore, it is important that our 
background research is thorough as there is much that can be learned from just taking the 
time to understand the culture and life style of the affected population.   
 
 While much of the background 
research on an area can be collected 
through an internal review of the 
existing literature there is a need for 
subject matter experts. To illustrate this 
idea and its usefulness, MERS-CoV will 
be used as another example.  During the 
investigation of the virus, it became 
necessary to understand more about 
camelids, the U.S. camelid industry, and 
the cultural differences between the 
U.S. and Middle East in regards to 
camelid health. To help fill these voids, 
Figure 2: Emerging Disease Notice (left) and Situation Report (Right); taken 
from APHIS website and APHIS-VS Microsoft SharePoint 
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a list of camelid experts was developed. The list consisted of several experts that could be 
consulted to answer questions and serve as future resources.  The information acquired at 
this stage promotes a working knowledge of a disease and enhances the ability to discuss 
risk assessment.  
 
Situation Reports and Emerging Disease Notifications 
Part of what should be included in the background information about an emerging 
disease is information to improve the awareness of the issue and enhance a stakeholder’s 
ability to stay informed as new information arises. Situation reports and emerging disease 
notices have been used by VS to achieve situational awareness of a particular EID. A 
situation report (Sit-Rep) can be updated as often as necessary and is distributed as 
determined by VS.  
 
For example, a situation report was developed for MERS-CoV to increase situational 
awareness related to the recent outbreak. A Sit-Rep includes information such as, cases 
reported, U.S. and international activities, notices from the World Health Organization 
(WHO), and the socioeconomic impact of the EID.  The logistics behind the distribution of a 
Sit-Rep requires a lot of coordination amongst federal agencies to ensure that reporting 
occurs seamlessly with minimal conflicts. In terms of the MERS-CoV Sit-Rep, the decision 
was made to distribute updates weekly due to the novelty and high volume of data 
reported. Since then the acquisition of new information on MERS-CoV has decreased. This 
has led to the decision to decrease the frequency of distribution to as needed. 
  
 The Center for Epidemiology and Animal Health (CEAH) has also contributed to the 
situational and scientific awareness of an EID through the development of emerging 
disease notices. The difference between an emerging disease notice and a situation report 
is the audience and format. An emerging disease notice is formatted like a technical fact 
sheet. It contains a summary of the outbreak and describes the current knowledge and 
epidemiology of the disease. It is often distributed at the public level to raise awareness 
and knowledge on an emerging issue. In comparison, a Sit-Rep is often restricted to 
distribution amongst the federal agencies and stakeholders. While, a Sit-Rep serves a 
valuable purpose, it is primarily a report of the activities related to the disease outbreak or 
situation. The emerging disease notices provide a more concise and readable description of 
the disease situation.  
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Chapter 4: Risk Assessment and Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risk assessment is a valuable tool in deciding whether there is a need for policy. The 
definition of risk can be described formally as anything that is likely to cause injury, 
damage or loss. The goal of the assessment is to examine each of the environmental factors 
affecting animal and human health. This evaluation produces a consequence or estimates 
the likelihood of a disastrous event. The quality of the risk assessment is dependent on the 
nature of the disease.  
 
In terms of a newly emerging disease, a 
risk assessment can have important limitations 
and challenges while trying to adequately 
assess risk. Consequently, it is these cases that 
strengthen the argument for further review and 
analysis of the associated risks as new 
information arises.  
Risk Identification and Assessment of an 
EID 
 In terms of an emerging infectious 
disease, a risk can be anything that impacts or 
threatens the viability of animal, human, or 
environmental health. To properly assess these 
risks and potential threats, a risk assessment 
framework is required. Figure 4, is a 
generalized template of the Risk Identification 
and Assessment process used by APHIS-VS. 
This outline was extrapolated from a 
preliminary risk assessment of Schmallenberg 
virus by CEAH (21). While the framework is 
Figure 3: OIE risk analysis process (taken from Voss, 2012) 
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likely to vary from disease to disease, VS strives to follow the OIE framework to the extent 
possible for all emerging diseases (18). Figure 3 briefly outlines the OIE risk analysis 
process.  
 
The Schmallenberg virus is a perfect example of a case where at the time of 
assessment the amount of detail known about the emerging disease was limited. However, 
the assessment was qualitative and categorized likelihoods using a list of terms. These 
terms ranged from negligible to very high potential of an event occurring (21). Risk 
assessment is a systematic process that strives to address all critical areas that may impact 
animal, human, and environmental health. Several groups of individuals across disciplines 
and agencies are often used to effectively collect and analyze the information required to 
fully elaborate on these areas of interest.  
 
Once the risk assessment process has been completed for a particular emerging 
issue, the assessment is made available to other health professionals, producers, and 
decision makers for public comment. If implemented appropriately, communication 
provides further insight into the issues and concerns that may require further 
consideration (27). However, the entire risk assessment process needs to be flexible and 
dynamic. The assessment is not fixed and should be subject to change at any time based on 
different sources of information.  Different sources can include additional concerns brought 
forth by external sources or from the acquisition of new information; developing a need for 
analysis and review of the current assessment. The product of the risk assessment and 
analysis process is heavily weighted in the decision making process and can consume a 
great deal of time and energy. A comprehensive risk assessment is imperative in building 
the foundation of sound policy. 
 
The Importance of Risk Communication 
The USDA Highly Pathogenic Avian Influenza Secure Egg Supply (SES) plan is a great 
example of how sound policy can be created as a result of a successful risk analysis. In 
2004, a private, public, and academic partnership 
was formed. This partnership was devised to 
address the U.S. Egg Industry’s concerns related to 
the current AI preparedness and response policy. 
The U.S. Egg Industry practices a “just in time” 
approach, meaning that eggs laid by hens, are 
processed and shipped within eight to twelve hours 
of being laid. This rapid turnover does not require a 
lot of storage space, thus a delay in shipment 
associated with movement restrictions to control a 
disease outbreak would quickly overwhelm 
available storage capacity (27).  
 
A proactive risk assessment, consisting of 
input from the Egg Sector working group (including 
egg processors and producers), two universities 
(Iowa State University and the University of 
Figure 5: APHIS-VS Impact Worksheet for the H5N1 
outbreak in Poland, December 2007 (taken from APHIS 
website) 
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Minnesota), and state and federal regulators, was created to address the concerns of the 
industry by assessing the actual risks associated with egg and egg product movement. The 
SES plan laid a solid foundation for risk management and helped strengthen the response 
by providing a more comprehensive preparedness plan. It also kept stakeholders actively 
involved throughout the entire process inciting a new level of trust which helps ensure a 
seamless response in the face of an AI outbreak. Additionally, it also kept stakeholders from 
becoming complacent (27).  
 
The SES plan has set the stage, by illustrating the impact that good risk 
communication can have on the success of a response plan, while also demonstrating the 
value of good working relationships. The concept of a unified, team based approach is an 
idea that is becoming more widely accepted, and can vastly improve the way to which 
future disease response plans are developed and implemented.  
 
Impact Assessments 
 An impact assessment is another assessment that is performed by the APHIS-VS 
community. The assessment is a preliminary assessment of an emerging disease that is 
drafted and released within 72 hours of its introduction (18).  For example, an impact 
assessment was drafted and released in response to the 2007 outbreak of HPAI-H5N1 in 
Poland.  This particular assessment is designed to raise awareness of the social and 
economic impacts of an outbreak, specifically as they relate to international trade. In this 
case, the risk to the U.S. was low due to import restrictions of poultry or poultry products 
from Poland, but to Europe and other countries the impact was significant. Poland exports 
a large percentage of its poultry and poultry products to Europe and much of the world 
market. The impact of trade restrictions and extensive disease control methods were 
estimated to cause significant economic losses for Poland. In addition, those countries that 
import poultry and poultry products from Poland were also at risk of introducing HPAI-
H5N1 into their country (19).  
 
 The impact assessment defines a different component of disease risk, the risk to 
international trade, and the impact it can have on the economic and social structure of an 
affected country and the world market. The benefit of understanding the potential 
economic impacts early on in an outbreak helps raise awareness of an issue, and identifies 
the necessity of rapid, effective control measures.  
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Chapter 5: Policy Development 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VS Authority 
 Before any action steps can occur, it must first be determined who has the authority 
to regulate and instigate a particular policy. The Federal government has given APHIS-VS 
both the statutory and regulatory authority to govern any action(s) related to the 
involvement of diseases or agents that impact animal health. However, the interpretation 
and application of this authority is less clear. Two acts have been created to grant authority 
to APHIS-VS. The Animal Health Protection Act (AHPA) assigns the responsibility of 
detection and response of animal diseases. The second act, Agro bioterrorism Protection 
Act – 9CFR121, designates authority in regards to biologic agents and toxins. The 
Homeland Security Presidential Directive-9 (HSPD-9) directs the USDA to work together 
with the other agencies to develop comprehensive, fully coordinated surveillance and 
monitoring systems (20).   
 
 
 
Develop a clear goal and define a plan 
The plan is dependent on the goal of the policy. Objectives can range from 
prevention to eradication and can be highly variable depending on the issue. In terms of 
MERS-CoV, the simple novelty and potential threat to U.S. animal and human health was 
enough to push for internal VS development of a standard operating procedure (SOP). This 
is being performed preemptively with the goal of future prevention and control of MERS-
CoV in the U.S.   
 
In other cases, the need for a plan arises after a disease outbreak is already 
established. PEDv is a good example of an ongoing outbreak that is currently ravaging the 
U.S. swine industry (16). The need for a plan related to PEDv came from many external 
pressures but predominately the stakeholders. The current goal for PEDv in swine herds is 
prevention and control of viral transmission. The option of eradication may be explored at 
Figure 6: Diagrammatic Representation of Federal Policy Development 
P a g e  | 17 
 
17 
 
a later date, but not enough is known about the virus and its pathogenesis for policy 
makers to be able to propose any viable eradication options.  
 
Eradication has proven effective in many areas. One of historical significance is the 
Accelerated Pseudorabies Eradication Program. The goal of Pseudorabies eradication was 
identified after the rise of severe economic loss to swine producers. The U.S. government 
then began to offer indemnity to producers in an effort to prompt immediate slaughter of 
all pigs in infected herds resulting in eradication of Pseudorabies. 
 
These last three examples demonstrate how the policy goal was influenced by 
economic and social pressures. MERS-CoV is a unique example because it involved an 
internal decision by VS. This is certainly not an all-inclusive list and in fact many times the 
goal and direction that VS must go is determined by a higher official. An example of higher 
intervention is the National Strategy for Pandemic Influenza. In this situation President 
Bush outlined a strategy and assigned the lead roles to which then left it up to the 
government agencies to fill in the details.  
 
 
How a bill becomes a law and its impact on policy development 
 
In order to appreciate a specific policy, it’s important to understand the process by 
which policies are made. While this is not an inclusive description, it is important to start 
with the initial framework. In many cases, the process begins with the introduction of a bill 
to Congress, and if received favorably by both houses and the president it becomes a law. 
These laws are the enabling authority for agencies to develop regulations. Regulations or 
rules provide the details about how the law will be implemented and organized under the 
Code of Federal Regulations (CFR). The CFR is formally defined as the compilation of 
general and permanent rules published in the Federal register by the executive 
departments and agencies of the Federal government. The CFR is further defined into fifty 
titles (3).  Title 9 of the CFR, Animals and Animal Products, is the section of the Code that is 
pertinent to the authority and roles designated to APHIS-VS.  
 
VS authority dictated by the AHPA allows VS to establish either a proposed rule or 
interim rule under the CFR. The only difference between the two rules is that an interim 
rule, once written, becomes effective immediately. One important similarity to note is both 
rules are subject to a sixty day comment period. It is within this sixty day comment period 
that the public is allowed to view and comment on the ruling. After this comment period, 
VS leadership reconvenes to discuss the public interpretation and comments, and then 
decides whether to finalize, change, or reject the rule completely. Another important 
component in this process is the contributions from APHIS-PPD or Policy and Program 
Development. This unit must also have a hand in the process to adequately analyze and 
assess the environmental and economic impact of the proposed policy or rule. It is in this 
way that we can assure that the proposed policy will benefit the economic status and not 
hinder environmental health (9).  
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If finalized, the proposed rule becomes a reality and the interim rule becomes 
permanent until it is replaced. At this point, VS authorities can establish a (agency) 
directive to internally assign direction to its employees regarding the new rule. The formal 
definition of a directive, as defined by APHIS, is “a permanent issuance that is in force until 
cancelled. Directives issue delegations of authority, basic policies, and operating 
instructions.” In short, a directive is a formal way for an agency to assign roles and 
instructions to ensure that a policy or ruling is achieved effectively. In addition to a 
directive, the agency may choose to establish an administrative notice which is a 
temporary, one-time issuance addressing a single subject or action. These are often used to 
address internal actions on short term programs, interim procedures, or make 
announcements. An administrative rule is only effective for one year and does not require a 
review period (9).  
 
While, the above description outlines the standard policy making process, it is 
important to keep in mind that not all policy is made through the same process. Policies are 
often created on a situational basis, and sometimes in unconventional ways. For example, it 
was brought to the attention of APHIS-VS that the Food Safety and Inspection Service 
(FSIS) has in place a directive instructing that all FSIS plant personnel report any 
identifications of bovine cysticercosis to VS. It was then realized that there were several 
inconsistencies in the VS response to the notifications. The inconsistencies prompted a 
necessary intervention by VS leadership.  A directive has been drafted as an informal 
guidance to define a minimum list of expected responses. The guidance is not meant to be 
an inclusive document, but a form of guidance to ensure a coordinated response is present 
in every case (5).  
 
 
 
 
Figure 8: APHIS Technical Fact Sheet for FMD (taken from APHIS 
Website) 
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MOUs, SOPs, and Technical Fact Sheets – what do these mean and what is their role in 
animal health policy? 
 
In addition to the VS directive, it may be necessary to establish additional 
documents to ensure that the overall goal is being achieved. One way that this can be done 
is through the development of a Memorandum of Understanding (MOU). A formal 
definition of a MOU is a document that describes broadly, concepts of mutual 
understanding, goals, and plans shared by parties (9). A recent example of a MOU is the 
collaborative effort between APHIS and FSIS on the matter of properly assessing the root 
cause of foodborne illness. Previously, these duties have primarily been of FSIS 
responsibility, but since one of the four emphases of VS is pre-harvest food safety it seemed 
imperative that these two agencies join forces (4). The goal that both agencies hope to 
achieve from this relationship is increased marketability and reduced foodborne illnesses. 
This continues to illustrate the value of the OH approach and the ability of the OHCC to 
further open the pipelines of communication between federal agencies.  
 
A standard operating procedure (SOP) is a more thorough explanation of the goal 
and actions that should be performed. This document is derived as a supportive document 
that defines a protocol to fulfill the overarching goals. Depending on the situation, an SOP 
can be developed before or after a directive. In the case of MERS-CoV, a SOP is being 
developed before an official directive to define a sampling and surveillance protocol that 
can be utilized in the event that it becomes necessary.  While there is no directive for 
MERS-CoV, if needed, VS leadership can initiate one later. To summarize, a directive is a 
permanent issuance of the roles and actions to be performed, and can refer to information 
provided in a SOP to further provide direction on an issue (9). 
 
Additionally, technical fact sheets can also serve a supportive role in policy 
development and communication. The development of such educational materials helps 
outline knowledge or perception of a topic, and explains the current methodology for 
prevention and control. For example, figure 8 provides a visual example of a technical fact 
sheet used by the APHIS-VS community to educate and to help enforce the prevention and 
control of Foot-and-Mouth disease (FMD).  The technical fact sheets serve a valuable role 
by keeping all stakeholders or interested parties adequately informed. This education 
builds the foundation for sound policy by ensuring implementation is relatively seamless 
during a FMD outbreak. 
 
Regulation analysis 
 After a regulation on a specified area of interest has been established, the next step 
is to determine how to assess its effectiveness. There are two separate review processes 
that can occur. One is a station or administrative review, which is essential but less focused 
on the actual program. It helps assure that the management and operations at the office 
level are appropriate. The other type of review is the program review, which is a review of 
the program at the field level. Both reviews are performed annually but not in every state. 
Two of the more common reasons for review of a state’s program, is a state previously 
identified with problems or a state that has not been reviewed in a couple years. It is during 
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these assessments that VS can determine if the goals are being met, and if the resources 
and funds are adequate (9).  
 
 As a result of the VS reorganization and change in the allotment of funds for the 
disease programs, the analysis of programs has now expanded to include not only the 
program diseases but also any emerging disease issue of OH concern. This is especially 
important as the emergence of new diseases continue to occur within the borders of the 
U.S. and abroad and further enhances the role of VS in their mission to effectively control 
and prevent diseases of OH concern.  
 
Social Media and its potential impact on policy development 
 Society is more modernized and technologically savvy than ever before. As 
smartphones, iPads, apps, and other electronic devices enhance the way we interact with 
the world, information is being shared every second.  How does social media influence the 
policy making process?  
 
The lines of communication between the public and politicians have become easier, 
as many politicians have adopted twitter accounts and use Facebook to communicate with 
the general public. Early in his presidency, President Obama became the first U.S. president 
to initiate a Facebook page with the attempt to enhance community outreach and 
communication. Additionally, governmental organizations have begun using GovDelivery, a 
multichannel distribution system, which allows them to deliver emergency notifications, 
build online communities, and track customer requests (33). The questions remain as to 
how the government can use this information in a useful way and also how it can impact 
our decisions both positively and negatively. 
 
 The more obvious way that social media could impact policy development is at the 
public awareness stage. This stage is defined as the initial comment period where the 
public has the chance to voice their opinions about the proposed rule. Social media could 
increase the awareness on an issue and allow more individuals to provide input. A 
potential downside would be effectively organizing this information in a way that it is 
useful. For example, FSIS is currently attempting to use social media outlets to aid in data 
collection of foodborne illnesses. (29) The idea is promising, but may be challenging due to 
the logistics of data transformation into a form that can be used effectively by the agency.  
 
 Another way that social media could influence the formulation of policy is through 
increased awareness of the issues. Society is striving to be more informed and the overall 
need to be transparent across disciplines has become a requirement. Social media can help 
create this transparency and increase individual and public knowledge in a variety of areas. 
For example, through the implementation of a disease outbreak and investigation app and 
the ‘Zombie apocalypse’ preparedness and response plan, the Centers for Disease Control 
and Prevention (CDC) is attempting to increase social awareness and get people excited 
about public health preparedness (34). 
 
Social media can also cause some challenges as increased public awareness of an 
ongoing issue, i.e. an emerging disease outbreak, could lead to added pressure from society 
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to initiate action. This would not always be a negative as it would still keep us informed of 
the concern and awareness of the issues, and it could make issues of social awareness a 
higher priority. Additionally, there is also the risk when information is distributed to large 
numbers of people that information will be misinterpreted or misconstrued.  
 
The future of social media is promising and its value as a tool for policy makers and 
other professionals is evident. It has its downsides, but the potential benefits could 
outweigh the costs overtime as the use of social media is refined as a policy making tool. 
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Chapter 6: Regulatory Affairs 
 
Reportable diseases – OIE vs. State 
 Whether a disease becomes reportable is dependent upon many factors, and the 
organization in charge of monitoring the disease is an important aspect. Historically, the 
OIE has developed a list of reportable diseases that it considers economically, politically, 
and socially important worldwide. This is fairly inclusive, but is subject to change as the 
OIE deems appropriate. For example, a conference call was hosted by APHIS-VS and 
included all fifty state veterinarians.  During this meeting, one of the talking points 
consisted of an update from the OIE and its plan to remove Vesicular Stomatitis from the 
OIE list of reportable diseases (1). This change will become effective as of January 1, 2015 
(31). 
 Figure 9, illustrates the 2014 listing of the diseases affecting multiple species that 
should be effectively reported by member countries (2). There are currently 180 member 
countries represented by the OIE, including the United States (32). OIE has also defined an 
additional list of diseases for each animal species that it deems significant to a particular 
class of animals.  
 
 The OIE, in addition to its list of 
reportable diseases, also maintains other 
regulations to protect its members. The 
OIE is currently the only organization 
worldwide to grant an official status of 
freedom from a specified animal disease.  
 
 The free status designation can 
describe a country as a whole or a 
particular zone. A couple of factors play 
into the designation of a member country 
for a specified disease status. The OIE 
must have a specified official recognition 
program for the disease and a request 
must be submitted from the delegate of 
the member country (14). For example, 
the United States is one of sixty four 
member countries recognized by the OIE 
as free of Foot-and-Mouth disease (35). 
 
 Not all OIE-listed diseases have an 
official recognition program for 
declaration of free status. An example of 
this is Avian Influenza. In cases, such as 
Avian Influenza, a country can self-
declare freedom as defined by the criteria 
and standards of the OIE Terrestrial 
Figure 9: 2014 OIE-listed multiple species 
diseases, infections, and infestations 
Anthrax 
Bluetongue 
Brucellosis (B. abortus, melitensis, and suis) 
Crimean Congo hemorrhagic fever 
Epizootic hemorrhagic disease 
Equine encephalitis, specifically Eastern 
Foot and mouth disease 
Heartwater 
Infection with Aujeszky’s disease virus 
Echinococcus granulosus, multilocularis 
Rabies 
Rinderpest 
Trichinella spp. 
Japanese encephalitis 
Cochliomyia hominivorax (New world screwworm) 
Chrysomya bezziana (Old world screwworm) 
Paratuberculosis 
Coxiella burnetti 
Rift valley fever 
Trypanosoma evansi 
Tularemia 
Vesicular Stomatitis*To be removed starting Jan 1, 
2015 
West Nile Virus 
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Animal Health Code (14). This helps member countries uphold and maintain trade 
agreements, and protect the agricultural commodities within their country.  
 
 The OIE list is important because it helps define diseases of worldwide importance 
that require effective monitoring or surveillance programs. This creates more pressure for 
policy development to ensure that a country maintains its current disease free status and 
controls diseases of importance for international trade. For example, the United States is 
not free of Salmonella pullorum, but for international trade to occur proper documentation 
may be required (as agreed on by delegates of each country) to define measures that must 
be performed to satisfy a trade agreement.  
 
 The USAHA Committee on Foreign and Emerging Diseases also creates and updates 
a list of foreign animal diseases. The committee consists of a group of selected individuals 
that meet annually. Similar to the OIE, the USAHA Committee on Foreign and Emerging 
Diseases adds or removes diseases as they deem appropriate. The collective list is compiled 
into a book, which over the years, has been referred to as the, “the gray book.” “The gray 
book” includes the list of foreign animal diseases with clinical descriptions and pictures. 
Through its development and with the support of various professionals, the gray book has 
continued to serve as an educational resource for private, public, and corporate 
veterinarians, and even veterinary students (30). 
 
 In addition to the guidelines set forth by the U.S. government, each of the fifty states 
has the right to establish added regulations for disease reporting. This is any disease that 
has been deemed economically or politically significant to a particular state. The minimum 
national standards do not preclude the adoption of more stringent regulations, but 
regulations dealing with interstate movement must comply with the federal standards. For 
example, in the State of Nebraska there is a legal requirement to report all Trichomoniasis 
cases to the state veterinarian on a monthly basis. In addition, the producer, in compliance 
with the state law, must also notify all surrounding farms of their positive status. This 
regulation was instated to protect cattle herds through effective monitoring and 
containment of the disease (17). 
 
 The topic of regulatory medicine is similar to the other components of policy 
development. It is often complex and can take time to sort out all the details, especially at 
the international level. Regulations become increasingly complex as emerging or re-
emerging diseases surface. Therefore, it is necessary to keep regulations flexible. This 
allows those responsible for drafting policies to adapt to fit the current economic, social, 
and political situation to effectively meet goals.  
 
Stakeholders 
 The role of stakeholders in regulatory medicine and policy development is best 
described by dividing the stakeholders into two separate groups. The first group consists of 
stakeholders representing the interests at the state or local level (20).  These members 
include local industry groups, producers, local and state veterinarians, public health 
veterinarians, and the state animal health officers. The individuals at this level are on the 
front lines during a disease outbreak or emerging issue. An issue generally arises from 
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reports of significant loss or illness in animal or human health. The focus is small scale with 
concern directed to the health of individual animals, herds, or humans within a state or 
community. The second group consists of the stakeholders representing the interests of the 
entire country (20). The national stakeholders include federal agencies and public 
organizations. The focus at this level is more broad and directed to the large scale effects of 
the emerging issue on animal, human, and environmental health.  
 
 A formal request for action on an area can arise from stakeholders at either level. 
For example, the current outbreak of PEDv in U.S. swine herds led to a request from local 
stakeholders for VS services. In comparison, the Pseudorabies program was initiated by 
national stakeholders to eradicate Pseudorabies and enhance the health status of U.S. 
swine herds. Both of these examples describe situations where the decision to initiate 
action directly benefited the animal health status. In contrast, a disease of OH concern may 
result in action being initiated by stakeholders for the benefit of human health. For 
example, the incidence of foodborne outbreaks associated with animal products, and the 
goal to reduce foodborne illnesses in humans. 
 
 Stakeholder interest plays a significant role in both influencing decisions and in the 
regulatory process. The goal of all stakeholders is the same, to maintain the health of 
animals, humans, and the environment. However, issues can arise due to communication 
failures and conflicts of interest. To alleviate these potential challenges, it is important that 
the lines of communication are open between stakeholders. The OHCC was created in 
partial fulfillment of this goal. The OHCC strives to further open and maintain these 
pipelines and enhance the relationship between stakeholders.  
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Chapter 7: Conclusion 
 
Final Thoughts 
 The past six chapters have provided a generalized overview and understanding of 
the policy making process, especially as it relates to complex animal diseases. The main 
take home point from this review is that there is no one size fits all approach to policy. 
Policy making is complex and a dynamic process. It could be said that policies are like 
Influenza viruses, evolving and changing, as a result of a variety of different factors, 
pressures, and situations.  
 
 A wise veterinary epidemiologist at Kansas State University once said, “It is not the 
facts or data that are most important but rather the concepts. Facts, figures, and data will 
inevitably change with time but it’s our conceptual understanding that is forever.” This is 
true for many areas but especially the OH concept. With the onset of emerging diseases 
coming onto the scene every minute, it is clearly evident the necessity for a team based 
approach. The OH concept lives through the ability of professionals, scientists, and many 
others within a variety of disciplines to work together towards a unified goal. In the case of 
OH, the goal is advancement of health at the level of the animal, human, and environmental 
interface.   
 
 Issues of OH concern may not always require policy, but one thing that will remain 
true far into the future is the need for an OH approach. The future success of all disciplines 
depends on this integrated, team based approach. It is only once this concept is realized by 
everyone that the goal of safeguarding animal, human, and environmental health can be 
fully optimized.  
 
Completing the puzzle 
 Over the course of the five years it took to complete my degree program, I can 
honestly say that I was able to obtain not only a deeper understanding but really ascertain 
a sincere appreciation for public and One Health. This realization would not have been 
achievable, however, without the ability to cap off my didactic studies. Prior to arriving at 
the APHIS headquarters in Riverdale, Maryland my head was full of knowledge, but while I 
knew I had been given all the pieces to a puzzle its complexity required some assistance to 
complete. This assistance as I soon discovered would come with time spent in the real-
world.  
 
 Early on in my field experience, I was fairly naïve to believe that I would simply be 
working on one project, and what I soon discovered was somewhat life and career 
changing. I quickly learned that working in a government setting requires a level of 
flexibility. Issues emerge and re-emerge frequently and often spontaneously, and in the line 
of federal work what becomes a priority can change amid a variety of outlets. Therefore, 
further requiring that you always be prepared, and just expect that you are never going to 
be working on just one issue.  
 
 In example of this can be described by discussing my initial project while with the 
OHCC. The recent emergence of MERS-CoV quickly made it an area of interest for the 
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APHIS-VS, SPRS Unit. To better understand the disease and epidemiology behind it part of 
my duties was to expand what was known. This included understanding not only camelids 
themselves but the cultural differences between us, the Middle East, and East Africa. The 
end result of this particular project was achieved through extensive literature reviews, 
google searches, and lengthy discussions with subject matter experts. Though, the most 
important lesson taken away from this particular project was the realization that my core 
training in public health laid the foundation by which I could start to culminate my 
experiences. I’ll admit while in the classroom such topics as the social and behavioral 
sciences were not nearly as exciting as learning about infectious disease processes, 
however, I began to appreciate them a lot more once I was faced with situations where this 
information became useful.  
 
 In retrospect, it is kind of interesting to look back and see just where my field 
experience took me. It went far beyond the brim of just digging up background information. 
In addition to providing assistance on various technical documents (fact sheets, Sit-Reps, 
etc.) my field experience mentor saw a unique opportunity to utilize my skills even more. 
He had discovered early on that I carried an apparent ability to take in a lot of information 
and somehow sort through it in a way that made comprehensible sense on paper. With this 
in mind, he came to me with the idea of developing an APHIS training document that 
discussed the complex yet important topic of animal health policy. Thus, how the topic of 
this paper was born.  
 
 This challenge soon sky-rocketed my field experience in terms of what I could have 
possibly expected to take away. In achieving this goal, I quickly found myself diving into 
public policy, and to do so required going outside of the SPRS unit of APHIS-VS.  I not only 
met individuals within each of the government agencies but also found myself spending 
some time on Capitol Hill. It was also during this time that I began to really integrate all 
that knowledge that had once just been seen as a mix of concepts, theories, and facts.  
 
 To summarize, a field or capstone experience is generally set at the end of a 
student’s studies to help them not only synthesize but begin to integrate the knowledge 
they have acquired throughout their course of study. Up until the point of my field 
experience, I had been charged with a substantial amount of information that like most 
students, I didn’t really know what to do with. The time I spent with the OHCC showed me 
the true value of the concepts that had collectively been laid before me over the past five 
years. It did exactly what a culminating experience should do by bringing all the pieces 
together, allowing me to begin to integrate, and utilize this knowledge. Finally, my puzzle 
was complete, but no good puzzle is without a missing piece. This piece is not anything that 
can be filled by a practicum, but rather represents the space required to grow and learn 
long into the future.  
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Appendix I 
 
Engagement Consideration and Response Alternatives Tool 
Circle the appropriate parameter in each row (e.g. species involved, or zoonotic 
transmissibility) to determine the level of engagement for the situation. More than 3 
selections in a column should guide decisions to the corresponding level of engagement for 
the situation.  
Example: MERS-CoV receives five selections from the Baseline Engagement column 
supporting a low level of engagement.  
 
Full  
Engagement 
Moderate 
Engagement 
Baseline 
Engagement 
No  
Involvement 
Species 
Involved 
Cattle, sheep,  
swine, poultry 
Horses,  
Farmed Cervids, 
Farmed aquaculture 
Wild cervids,  
feral swine, wild fish, 
wild horses,  
domestic pets,  
zoo animals, insects 
Animals not 
involved 
Animal 
Prevalence 
Agent not thought to 
exist in susceptible 
population 
Agent exist at low to 
moderate levels in 
population 
Agent is endemic or 
highly prevalent in 
species 
Agent is not 
found nor 
infectious in 
animal species 
Animal 
Transmissibility 
Agent highly 
transmissible within 
and between species 
Moderate 
transmissibility within 
species 
Animal transmission 
unlikely, limited or 
uncertain 
No known 
animal 
transmission 
Animal 
Consequences 
High mortality/ 
morbidity in species of 
concern 
Serious illness and 
moderate economic 
loss in species of 
concern 
Little, unknown or 
uncertain illness in 
species of concern 
Animal 
infection 
unlikely 
Host  
Species 
Primary host is  
"farm" species 
Secondary host is  
farm species 
Host range is  
unknown or uncertain 
OR 
VS-covered species are 
unlikely hosts 
Exclusive 
human 
pathogen 
Zoonotic 
Transmissibility 
Zoonotic transmission 
likely or common 
Known zoonotic 
transmission of 
moderately 
transmissible agent 
Zoonotic transmission 
unlikely, limited or 
uncertain 
No known 
zoonotic 
transmission 
Human 
Consequences 
Agent is potentially 
fatal to humans 
Agent causes serious 
illness in humans 
Human illness 
asymptomatic or mild 
Human 
infection 
unlikely 
Stakeholder 
Interest/ 
Concern 
High pressure, 
interest, request 
expectation 
Moderate level of 
pressure, interest, 
request for 
engagement 
Little pressure, 
interest, request for 
engagement 
No pressure, 
interest, 
request  for 
engagement 
Possible Actions 
Surveillance 
Vaccination 
Diagnostic Testing 
Movement Restriction 
Eradication 
Gather Information 
(surveillance, epi 
investigation/study) 
Support 
In Kind Support  
or Advisory 
Subject Matter Expert 
No Activities 
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Appendix II 
Response Alternatives 
If the Response Alternatives Tool suggests Moderate to Full Engagement, District Field 
Offices are encouraged to contact the OHCC or the Chief Epidemiologist to assist in further 
evaluation and routing of information to the appropriate units and leaders within VS. 
Example: MERS-CoV reveals a requirement for Baseline Engagement or an advisory role by 
VS.  
 
Full Engagement Moderate Engagement Baseline Engagement  
VS as Lead Agency VS in Supporting Role VS in Advisory Role 
VS action necessary to safeguard 
animal and/or human health 
Event involving livestock Event involving animals 
Possible Actions: 
• Lead other agencies 
• Lead animal health aspect if 
multi-agency 
• Provide guidelines  
• Commit resources for disease 
control 
(e.g., surveillance, vaccination, 
movement restrictions) 
• Commit resources for surveillance 
design and implementation 
- e.g., sample collection, testing, 
and reporting 
• Possible setting and enforcing 
rules, regulations 
• Regulate testing 
• Facilitate vaccine approval and 
importation 
Deploy VSAT 
Possible Actions: 
• Gather information 
- Situation report 
- Epi investigation/study 
- Collect information in 
NAHMS study 
- Deploy epidemiologic 
investigation team 
- Risk assessment 
- Cost/benefit option 
analyses 
- Surveillance analysis of 
existing information 
• Lead other agencies by setting 
direction 
- VS has information, skills, 
supplies, services to provide 
• Help implement 
recommendations made by VS 
or other stakeholders 
Possible Actions: 
• Provide in-kind support:  
time, knowledge, skills, 
information 
• Monitor situation 
• Use expertise to make 
recommendations 
• Provide education related to 
VS and animal health 
• Conduct discussions with 
stakeholders 
- Surveillance analysis of 
existing information 
- Risk Assessment 
- NAHMS study 
- Sampling or small scale 
surveillance 
- Cost/benefit option 
analyses 
 
- Varied cost—minimal to 
substantial 
- Varied resources—minimal to 
substantial 
- Another agency is lead 
- Minimal resource requirements 
- Limited to no resources 
required 
 
 
